70%
The global market share of Olympus in the field of gastrointestinal endoscopy is approximately 70%.
More than
1,200
different EndoTherapy devices, serving as a comprehensive portfolio for endoscopic diagnosis and treatment procedures.
THUNDERBEAT
Its unique integration of bipolar and ultrasonic energy has made THUNDERBEAT the fastest growing energy device. 3
Top 100 Global Innovator company 2
Over
65years of contribution to early diagnosis.
Inventor of the
world’s first practical
gastrocamera
7.35 million colonoscopies (approximately) are performed annually with Olympus endoscopes in Europe. Endoscopic colonoscopy is the most effective method for the early detection of colorectal cancer. 1
Over
6,700
patents held in the medical business.
More than
500 fully integrated ORs from Olympus have been installed across Europe since the introduction of the first integrated operating theatre a decade ago.
1 Zauber, Ann et al. (2012): Colonoscopic Polypectomy and Long-Term Prevention of Colorectal-Cancer Deaths, in: The New England Journal of Medicine, 366: 687-696.
2 http://top100innovators.stateofinnovation.com/
3 Based on internal analysis.
Olympus has been working closely with healthcare professionals continuously since the invention of the world’s first practical gastrocamera. Our mutual mission is to identify better, more economical solutions to medical issues. Olympus matches our innovative capabilities in medical technology and precision manufacturing with professional medical skills, providing the best possible outcomes for patients and society as a whole.
Olympus is fully committed to conducting partnerships between the industry, healthcare professionals (HCP), and healthcare organisations (HCO), in a fair, ethical manner and in full compliance with the laws and regulations. This includes:
Find out more about compliance at Olympus.
Olympus provides a comprehensive lineup of solutions for early diagnosis and minimally invasive therapy, suitable for a range of diseases. Our pioneering experience in these fields has led us to develop unique technologies and services, which match and often exceed physicians’ and surgeons’ increasing demands. Simultaneously, our technologies and services help to improve the quality of life of patients, as well as reduce the likelihood of readmission and potential healthcare expenses.
